This text investigates the potential of proteinase and peptidase inhibitors as critical targets for the development of novel therapeutic agents. Author Stephen Baguley compiles research on the physiological roles of cellular proteinases in both healthy and diseased states. The book provides a structured framework for understanding enzyme classes, inhibitor types, and the regulatory mechanisms that govern proteinase activity, emphasizing structural classification over traditional pharmacological categorization.

Researchers in medicinal chemistry and pharmacology utilize this text as a technical reference for understanding enzyme-inhibitor interactions. Experts note the specialized nature of the content, which serves as a resource for those engaged in drug design and molecular biology research.